LVAD survival: For all circulatory support devices (lvad, rvad, bivad, tah), the survival rate of patients after 6 months is 71% and at 1 year is 56%. All of these devices, except lvad, serve as a “bridge” to help patients survive until cardiac transplantation. Lvads (left ventricular assist device) replace the pumping function of a failing left heart and can be used as a true therapy in some patients. The surv.
Answered 1/14/2018
6.1k views
Lvad survival: Survival of patients with LVADs is about 70% at 1 year, and 60% at 2 years. While the pumps may function indefinitely, patients may develop progression of other diseases or complications which limit survival. These devices are relatively new so long term data is still being gathered. The longest support on record in the US is 6 years.
Answered 8/7/2018
6.1k views
A doctor has provided 1 answer
8 doctors weighed in across 3 answers
5 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question